News

Four brands hit with price cuts

Posted 7 April 2026 AM

Four brands have seen first new brand competition this month, meaning they're hit with a 25 per cent statutory reduction in price.

Progesterone was moved to the F1 formulary in April, although there is already several brands and forms funded through the PBS. Combined, they earned $21.5 million in pre-rebate R/PBS reimbursements in the 12 months ending February 2026. They'll face a 25 per cent reduction now that Boucher & Muir's Progesterone ADVZ and Progesterone BNM are listed on the PBS.

To see the whole article, please login